Eirini Papapetrou is an Associate Professor in the Division of Hematology & Oncologyand also in the division of the Department of Oncological Sciences in Mount Sinai. She is a member of Tisch Cancer Institute and Black Family Stem Cell Institute in the Mount Sinai School of Medicine.

She developed technologies for the derivation of patient-specific induced pluripotent stem cells (iPSCs) and contributed some of the earliest proof-of-principle studies for the use of iPSCs in disease modeling and regenerative medicine.

Eirini Papapetrou was born in Athens in 1975 and raised in Aigion. She has received her medical degree and her PhD in Molecular Genetics from the University of Patras in Greece.

In 2012 she also started her independent laboratory at the University of Washington. The focus of Papapetrou lab focuses on modeling malignant and non-malignant blood disorders with human pluripotent stem cells using cellular reprogramming and genome editing technologies. A research has established the first iPSC models of Myelodysplastic Syndromes that offer unprecedented opportunities for functional genetics studies to understand the disease mechanisms, study cancer progression and test drugs.

Her group developed new tools to generate transgene-free human iPS cells and to genetically engineer them in safe harbor sites in the human genome and new approaches to generate safer genetically modified iPS cells for cell therapies.

In 2014 Papapetrou joined Mount Sinai as an Associate Professor in the Division of Hematology & Oncology and also in the division of the Department of Oncological Sciences. She is a member of Tisch Cancer Institute and Black Family Stem Cell Institute in the Mount Sinai School of Medicine.

During her career, Papapetrou received numerous awards. In 2010, she received the Excellence in Research Award from the ASGCT and in 2011 the NIH K99/R00 Pathway to Independence Award. In 2013 the ASH Scholar Award, the University of Washington Research Royalty Fund Award, the Sidney Kimmel Foundation Scholar Award, the Aplastic Anemia & MDS International Foundation Research Grant Award, the John H. Tietze Stem Cell Scientist Award and the Ellison Medical Foundation New Scholar in Aging Award. In 2014 she was awarded with the Damon Runyon-Rachleff Innovation Award and the American Society for Clinical Investigation Young Physician-Scientist Award.